The inaugural meeting of the International Alliance for Life Extension Research was successfully concluded
Release time:
2023-03-29

On March 28, 2023, the kick-off meeting of the International Alliance for Life Extension Research was held in Jinan, Shandong. "International Alliance for Life Extension Research" by Shandong Yin
Initiated by Feng Life Science Research Institute, it was jointly established by 13 international scientific research institutions engaged in the field of cryogenic biomedicine from North America, Europe, Oceania, etc.
And all appeared at the conference in the form of online and offline.
The conference was hosted by Shandong Yinfeng Life Science Research Institute, co-organized by Shandong Refrigeration Society and Advertising Research Center of Shandong University, and counsellor of Shandong Provincial Government
Relevant leaders of Nanshi Science and Technology Bureau, Jinan Municipal Health Commission, Jinan High-tech Entrepreneurship Service Center and other departments, as well as Shandong University and Shandong University
Experts from Qilu Hospital and other cooperative units attended the meeting.


Mr. Chen Xiaoyang, Chairman of the China Executive Committee of the UNESCO Commission on Ethics, Science and Social Development, and Aaron Drake, representative of foreign experts
Mr. Liu Zhicheng, executive vice president of Shandong Yinfeng Life Science Research Institute, delivered a speech at the conference.


The logo of the International Alliance for Life Extension Research was released at the meeting, and the logo of the International Alliance for Life Extension Research was "Promoting International Life Extension Research Collaboration".
The original intention of the design conveys to the world the beautiful vision of working together, unity and friendship. The logo is designed in a circular shape as a whole, representing completeness and perfection. Earth, wheat
The elements of spikes, hands, and snowflakes represent internationality, hope, and unity, respectively
and cryogenic scientific research.

At the kick-off meeting, the participating institutions signed the "International Alliance for Life Extension Research" Initiative.

The purpose of this conference is to exchange academic exchanges in the field of cryogenic biomedical preservation, and members of Yinfeng Life Extension Program watched the whole conference online, focusing on "science and technology
Keynote speeches and on-site exchanges were held on topics such as "innovation" and "future technology". Biostasis Technologies (USA), SOCIÉTÉ CRYONI
CS DE FRANCE (France), Southern Cryonics and CryoPath (Australia), University of Surrey (UK), To
13 foreign institutions, including morrow Bio / European Biostasis Foundation (Switzerland/Germany) and University of Seville (Spain).
Participate and share topics.


Human cryopreservation is regarded as one of the research programs beyond the limits of human beings in the field of life science and future medicine.
Molecular biology, clinical medicine, regenerative medicine, nanotechnology, computer science and ethics are many interdisciplinary disciplines, so they are called the life sciences of the 21st century
"Lighthouse Project". Human cryopreservation aims to protect human cells, tissues and organs by exploring and applying advanced cryomedical technology, slowing down or even suspending them
Metabolism and apoptosis of human cells and tissues, maintain the physiological function and integrity of human cells and tissues, block the process of functional failure and "death", and allow life to exist
"Continuity" in ultra-low temperature environments.

Innovation drives development, science and technology create the future. The "International Alliance for Life Extension Research", initiated by Shandong Yinfeng Life Science Research Institute, will unite with International Cryogenics
Biomedical research institutions together take the development of biomedical technology for all mankind as their own responsibility, and gradually establish an international low-temperature biomedical research results sharing platform for people
The dream of life-like continuation works together and walks together in pursuit of dreams.
Next article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.